Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis.

Ruiliang ChenYushuai YuJie ZhangChuangui SongChuan Wang

Published in: Expert review of anticancer therapy (2024)

PROSPERO Registration: CRD42024538948. International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) registration number INPLASY202440092.

Keyphrases

early breast cancer
systematic review
rectal cancer
meta analyses
lymph node
locally advanced
high throughput
case control
randomized controlled trial
squamous cell carcinoma